President Moon Meets with CureVac CEO in Germany: "Strengthening Vaccine Cooperation"

[Image source=Yonhap News]

[Asia Economy Reporter Lee Ji-eun] On the 15th (local time), President Moon Jae-in held a video conference with Franz Werner Haas, CEO of CureVac, in Vienna, Austria, urging the strengthening of vaccine cooperation.

CureVac is a company developing not only mRNA-based COVID-19 vaccines but also second-generation vaccines capable of responding to variant viruses.

President Moon introduced that during the recent G7 summit, he met with Chancellor Merkel and agreed on cooperation between Germany, a leading country in vaccine development, and South Korea, which has strengths in vaccine production. He emphasized that South Korea is pursuing the establishment of a global vaccine hub. He also wished for the success of CureVac's mRNA-based COVID-19 vaccine development.

In response, CEO Haas expressed agreement with South Korea's excellent vaccine production capabilities and showed interest and support for the global vaccine hub policy.

Taking this meeting as an opportunity, South Korea and CureVac recognized the importance of vaccine cooperation and plan to continue discussions for ongoing collaboration. President Moon said, "The government of the Republic of Korea is mobilizing all its capabilities to overcome COVID-19 as soon as possible," adding, "To this end, we will actively cooperate with all countries around the world, including Germany."

Minister of Health and Welfare Kwon Deok-cheol and CureVac Chief Commercial Officer (CCO) Antony Blang attended the video conference.

This content was produced with the assistance of AI translation services.